Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
761
-
762
-
763
-
764
-
765
-
766
-
767
-
768
Retinoic acid alleviates decreases of phospho-Akt and phospho-Bad expression caused by MCAO damage.
Published 2024“…Molecular weight (kDa) are depicted at right. Data (<i>n</i> = 5) are represented as mean ± S.E.M. *<i>p</i> < 0.001, **<i>p</i> < 0.01 vs. vehicle + sham animals, #<i>p</i> < 0.01 vs. vehicle + MCAO animals.…”
-
769
-
770
-
771
-
772
-
773
-
774
The NK1-receptor antagonist ezlopitant significantly and selectively decreases voluntary intake of both sucrose and ethanol.
Published 2013“…<p>Ezlopitant decreased consumption of 5% sucrose (<b>A</b>), whereas only the highest dose of ezlopitant (10 mg/kg) decreased consumption of 20% ethanol (<b>B</b>). …”
-
775
-
776
-
777
Pharmacologically induced torpor by 5′-AMP does not decrease platelet count despite decreased body temperature.
Published 2014“…<p>A) Pharmacologically induced torpor by 5′-AMP in mice does not decrease platelet count during torpor and shows an increase upon arousal. …”
-
778
-
779
The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of non-caloric saccharin solution.
Published 2013“…<p>Ezlopitant (5 and 10 mg/kg) significantly decreased consumption of the non-caloric 0.2% saccharin solution compared to vehicle. …”
-
780